LI
AZN icon

LMCG Investments’s AstraZeneca AZN Stock Holding History

LMCG Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$997K Sell
5,258
-284
-5% -$53.4K 0.05% 168
2026
Q1 		$1.09M Sell
5,542
-829
-13% -$160K 0.07% 155
2025
Q4 		$1.17M Sell
6,371
-4,175
-40% -$732K 0.07% 152
2025
Q3 		$1.62M Sell
10,546
-330
-3% -$49.9K 0.1% 137
2025
Q2 		$1.52M Sell
10,876
-578
-5% -$81K 0.1% 142
2025
Q1 		$1.68M Sell
11,454
-303
-3% -$43.8K 0.11% 146
2024
Q4 		$1.54M Sell
11,757
-8,423
-42% -$1.18M 0.09% 146
2024
Q3 		$3.14M Sell
20,180
-1,007
-5% -$163K 0.19% 118
2024
Q2 		$3.3M Sell
21,187
-116
-0.5% -$17.5K 0.19% 118
2024
Q1 		$2.89M Sell
21,303
-1,047
-5% -$139K 0.17% 125
2023
Q4 		$3.01M Sell
22,350
-427
-2% -$55.5K 0.19% 122
2023
Q3 		$3.08M Sell
22,777
-1,072
-4% -$146K 0.21% 117
2023
Q2 		$3.41M Sell
23,849
-824
-3% -$121K 0.22% 116
2023
Q1 		$3.43M Sell
24,673
-170
-0.7% -$22.9K 0.23% 115
2022
Q4 		$3.37M Buy
24,843
+371
+2% +$46.5K 0.24% 115
2022
Q3 		$2.68M Buy
24,472
+1,932
+9% +$245K 0.2% 132
2022
Q2 		$2.98M Sell
22,540
-324
-1% -$42.5K 0.21% 126
2022
Q1 		$3.03M Buy
+22,864
New +$2.74M 0.18% 139

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

LMCG Investments's AZN Position: Q2 2026 in Review

LMCG Investments reduced its AstraZeneca (AZN) stake by 5.1% in Q2 2026, selling an estimated $53.4K and leaving 5,258 shares worth $997K. The position accounts for 0.05% of the portfolio, ranked #168.

LMCG Investments first reported a position in AZN in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.43M in Q1 2023. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • LMCG Investments held 5,258 shares of AstraZeneca worth $997K as of Q2 2026.
  • LMCG Investments sold 284 AstraZeneca shares in Q2 2026, an estimated $53.4K.
  • AstraZeneca made up 0.05% of LMCG Investments's portfolio in Q2 2026, its #168 holding.
  • LMCG Investments first reported a position in AstraZeneca in Q1 2022 and has held it in 18 quarters since.
  • LMCG Investments's AstraZeneca position peaked at $3.43M in Q1 2023.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.